We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$512M
AUM Growth
+$116M
Cap. Flow
+$1.26M
Cap. Flow %
0.25%
Top 10 Hldgs %
44.62%
Holding
138
New
35
Increased
30
Reduced
28
Closed
26

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.8M
2
BIIB icon
Biogen
BIIB
+$21.2M
3
NVS icon
Novartis
NVS
+$19M
4
PFE icon
Pfizer
PFE
+$13M
5
CELG
Celgene Corp
CELG
+$8.38M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$13.8M
2
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
+$13M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$11.9M
4
MRK icon
Merck
MRK
+$9.86M
5
AKAO
Achaogen Inc
AKAO
+$6.46M

Sector Composition

Rank Sector Weight
1 Healthcare 59.43%
2 Technology 4.38%
3 Communication Services 1.99%
4 Industrials 1.8%
5 Consumer Discretionary 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRVN
101
DELISTED
Trevena, Inc.
TRVN
$429K 0.08%
+187
New +$637K
UNH icon
102
UnitedHealth
UNH
$376B
$328K 0.06%
2,000
+300
+18% +$49.1K
MHK icon
103
Mohawk Industries
MHK
$7.5B
$252K 0.05%
1,100
– –
LOW icon
104
Lowe's Companies
LOW
$117B
$214K 0.04%
2,600
– –
TMX
105
DELISTED
Terminix Global Holdings, Inc.
TMX
$209K 0.04%
+7,465
New +$194K
SEE
106
DELISTED
Sealed Air
SEE
$196K 0.04%
4,500
+1,000
+29% +$47K
CMG icon
107
Chipotle Mexican Grill
CMG
$47.2B
$178K 0.03%
+20,000
New +$165K
TRIP icon
108
TripAdvisor
TRIP
$1.65B
$173K 0.03%
+4,000
New +$190K
ULTI
109
DELISTED
Ultimate Software Group Inc
ULTI
$156K 0.03%
+800
New +$156K
KRNT icon
110
Kornit Digital
KRNT
$705M
$17K ﹤0.01%
+900
New +$14.8K
ATHX
111
DELISTED
Athersys, Inc. Common Stock
ATHX
$1K ﹤0.01%
+31
New +$991
ABUS icon
112
Arbutus Biopharma
ABUS
$857M
– –
-22,000
Closed -$54K
APD icon
113
Air Products & Chemicals
APD
$65.7B
– –
-21,165
Closed -$3.04M
AZN icon
114
AstraZeneca
AZN
$263B
– –
-25,000
Closed -$1.37M
BA icon
115
Boeing
BA
$171B
– –
-8,392
Closed -$1.31M
BMRN icon
116
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-45,000
Closed -$3.73M
CABO icon
117
Cable One
CABO
$227M
– –
-500
Closed -$311K
CTSH icon
118
Cognizant
CTSH
$24.9B
– –
-27,875
Closed -$1.56M
FIS icon
119
Fidelity National Information Services
FIS
$23.1B
– –
-43,503
Closed -$3.29M
OTLK icon
120
Outlook Therapeutics
OTLK
$183M
– –
-1,090
Closed -$525K
PANW icon
121
Palo Alto Networks
PANW
$270B
– –
-42,312
Closed -$882K
PCRX icon
122
Pacira BioSciences
PCRX
$1.04B
– –
-50,000
Closed -$1.61M
PTCT icon
123
PTC Therapeutics
PTCT
$5.68B
– –
-150,000
Closed -$1.64M
SITE icon
124
SiteOne Landscape Supply
SITE
$4.12B
– –
-8,820
Closed -$306K
VRTX icon
125
Vertex Pharmaceuticals
VRTX
$121B
– –
-45,000
Closed -$3.31M
2 3 4
5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2017 Portfolio in Review

As of Q1 2017, Sphera Funds Management held 138 positions worth $512M, up 29% from $395M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sphera Funds Management's Q1 2017 filing shows 35 new, 30 increased, 28 reduced and 26 closed positions. Its largest new stake was Biogen: 75,000 shares worth $20.5M. The largest sale was Alexion Pharmaceuticals, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Sphera Funds Management's largest Q1 2017 buy was Biogen: 75,000 shares worth $20.5M.
  • Sphera Funds Management added most to Shire pic in Q1 2017, an estimated $31.8M increase.
  • Sphera Funds Management's biggest Q1 2017 reduction was Teva Pharmaceuticals, cutting an estimated $11.9M.
  • Sphera Funds Management fully exited Alexion Pharmaceuticals in Q1 2017, selling an estimated $13.8M.
  • Sphera Funds Management's ten largest holdings make up 45% of its $512M portfolio in Q1 2017.
  • Sphera Funds Management opened 35 new positions and closed 26 in Q1 2017.
  • Sphera Funds Management's portfolio value rose 29% quarter-over-quarter to $512M.

Based on Sphera Funds Management's 13F filing for Q1 2017, filed 11 May 2017.